The key reasons why Chembio Diagnostics Inc. (CEMI) is -87.77% away from 52-week high?

0
12

Chembio Diagnostics Inc. (NASDAQ: CEMI) started the day on November 23, 2022, with a price increase of 5.56% at $0.28. During the day, the stock rose to $0.30 and sunk to $0.255 before settling in for the price of $0.27 at the close. Taking a more long-term approach, CEMI posted a 52-week range of $0.23-$2.33.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 21.80%. Meanwhile, its Annual Earning per share during the time was -2.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -4.30%. This publicly-traded company’s shares outstanding now amounts to $36.71 million, simultaneously with a float of $36.31 million. The organization now has a market capitalization sitting at $10.15 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3352, while the 200-day Moving Average is $0.6402.

It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 337 employees. For the Profitability, stocks gross margin was +27.86, operating margin was -50.20 and Pretax Margin of -71.03.

Chembio Diagnostics Inc. (CEMI) Ownership Facts and Figures

Now let’s turn our focus to how large-scale investors are working with this stock of the Diagnostics & Research Industry. Chembio Diagnostics Inc.’s current insider ownership accounts for 1.08%, in contrast to 8.80% institutional ownership.

Chembio Diagnostics Inc. (CEMI) Earnings and Revenue Records

In the latest quarterly report released, which was put into the public domain on 3/30/2022, the organization reported -$0.29 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.21) by -$0.08. This company achieved a net margin of -70.90 while generating a return on equity of -109.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Chembio Diagnostics Inc.’s EPS decrease for this current 12-month fiscal period is -4.30% and is forecasted to reach -1.27 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 25.00% through the next 5 years, which can be compared against the -2.10% growth it accomplished over the previous five years trading on the market.

Chembio Diagnostics Inc. (NASDAQ: CEMI) Trading Performance Indicators

Let’s observe the current performance indicators for Chembio Diagnostics Inc. (CEMI). It’s Quick Ratio in the last reported quarter now stands at 1.00. The Stock has managed to achieve an average true range (ATR) of 0.03. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.17.

In the same vein, CEMI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.19, a figure that is expected to reach -0.19 in the next quarter, and analysts are predicting that it will be -1.27 at the market close of one year from today.

Technical Analysis of Chembio Diagnostics Inc. (CEMI)

If we take a close look at the recent performances of Chembio Diagnostics Inc. (NASDAQ: CEMI), its last 5-days Average volume was 0.17 million that shows plunge from its year to date volume of 0.68 million. During the previous 9 days, stock’s Stochastic %D was recorded 54.74% While, its Average True Range was 0.0360.

LEAVE A REPLY

Please enter your comment!
Please enter your name here